When are results of single-arm studies dramatic?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://www.nature.com/articles/s41571-020-00429-1.pdf
Reference9 articles.
1. Tang, H. et al. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials. J. Clin. Oncol. 28, 1936–1941 (2010).
2. Zia, M. I., Siu, L. L., Pond, G. R. & Chen, E. X. Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens. J. Clin. Oncol. 23, 6982–6991 (2005).
3. Seymour, L. et al. The design of Phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the National Cancer Institute Investigational Drug Steering Committee. Clin. Cancer Res. 16, 1764–69 (2010).
4. Lara, P. N. & Redman, M. W. The hazards of randomized phase II trials. Ann. Oncol. 23, 7–9 (2012).
5. Korn, E. L., Freidlin, B., Abrams, J. S. & Halabi, S. Design issues in randomized phase II/III trials. J. Clin. Oncol. 30, 667–671 (2012).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs;Expert Review of Clinical Pharmacology;2024-04-21
2. Single‐arm trials for US Food and Drug Administration cancer drug approvals;Cancer;2023-05-09
3. Single-arm trials supporting the approval of anticancer medicinal products in the European Union: contextualization of trial results and observed clinical benefit;ESMO Open;2023-04
4. Clinical effectiveness of training for awareness, resilience, and action for adolescents and young adults with depression: The pilot phase of a multicenter randomized controlled trial;Frontiers in Psychiatry;2023-03-31
5. Enriching single-arm clinical trials with external controls: possibilities and pitfalls;Blood Advances;2022-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3